Variable | Poor performance on substance use PROM n (%) | Unadjusted association | Adjusted association | ||
---|---|---|---|---|---|
ORa | 95% CIb | aORc | 95% CI | ||
Gender | |||||
Male | 265 (32.3) | Reference | Reference | ||
Female | 82 (28.8) | 0.84 | 0.61–1.19 | 0.57 | 0.35–0.93* |
Race | |||||
Black African | 30 (37.9) | Reference | Reference | ||
Colouredd | 265 (29.8) | 0.69 | 0.42- 1.15 | 1.24 | 0.38–4.08 |
White | 51 (40.2) | 1.10 | 0.75–1.61 | 2.07 | 0.76–5.63 |
Indian | 1 (8.3) | 0.15 | 0.02–1.19 | 0.11 | 0.00–5.53 |
Age (M, SE) in years | 33.31 (0.59) | 1.01 | 1.00–1.02* | 1.01 | 0.99–1.04 |
Education | |||||
Not completed school | 157 (29.3) | 0.83 | 0.62–1.11 | – | |
Employment | |||||
Employed | 93 (32.3) | 1.06 | 0.57–1.95 | – | |
Comorbid physical noncommunicable disease | 40 (38.5) | 1.51 | 0.66–3.42 | – | |
Comorbid mental health | 40 (35.7) | 1.32 | 1.06–1.66** | 1.41 | 1.02–2.05* |
Primary substance | |||||
Stimulants | 121 (28.8) | 0.94 | 0.46–1.92 | - | |
Heroin | 99 (32.5) | 1.12 | 0.52–2.39 | ||
Cannabis | 23 (37.1) | 1.37 | 0.82–2.28 | ||
Methaqualone | 21 (24.7) | 0.76 | 0.17–3.52 | ||
Alcohol | 46 (30.1) | Reference | Reference | ||
Polysubstance use | 185 (28.4) | 1.56 | 1.19–2.05*** | 1.68 | 1.11–2.55* |
Chronicity: years of use (M, SE) | 14.66 (0.59) | 1.01 | 0.99–1.02 | 0.98 | 0.96–1.01 |
Frequency of use | |||||
Daily | 199 (25.8) | 0.89 | 0.31–2.50 | – | |
2–6 times per week | 77 (38.1) | 1.22 | 0.34–4.46 | ||
Weekly | 6 (23.1) | 0.54 | 0.09–3.22 | ||
Monthly | 4 (22.2) | Reference | |||
Prior SUD treatment | |||||
No | 154 (26.0) | Reference | Reference | ||
Yes | 164 (32.4) | 1.18 | 0.91–1.54 | 1.08 | 0.73–1.61 |
Treatment intensity Outpatient | 229 (33.3) | Reference | – | ||
Residential | 118 (28.2) | 0.78 | 0.38–1.61 | ||
State-funded treatment | |||||
Yes | 262 (31.3) | 0.98 | 0.43–2.21 | – | |
No | 85 (31.7) | Reference | |||
Did not complete treatment | 21 (46.7) | 1.97 | 1.06–3.68* | 3.03 | 1.33–6.86** |
Treatment quality perceived as suboptimal | 230 (73.0) | 16.31 | 0.97–24.25*** | 20.82 | 13.59–31.88*** |